For genotype 1 treatment naive patients, the treatment will be Sofosbuvir in combination
with RBV and
peg-IFN for patients with genotype 1, 4, 5 and
6 HCV infection. So the next new treatment to come to market in early 2014 for genotype 1 patients will have peg-interferon.
Secondly, ultrasound does not stage liver disease. ONLY a biopsy or a non evasive liver stiffness measurement (LSM) can do that.
Clonazepam is a benzodiazepine.